Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders
Price: $1.77 Volume: 23,495
Change: $-0.04 % Change: -2.21%
Day High/Low: 1.87/1.77 52 Week High/Low: 2.76/1.12
Last Traded: March 27, 2015 11:58 Transaction Volume: 100
Open: 1.82 Previous Close: 1.81
Bid: 1.75 Ask: 1.79
Bid Size: 15900 Ask Size: 300
Market Cap: 181.5m Shares Out: 102.6m
PE Ratio: N/A Dividend Yield: N/A


Canadian Biotech comes back to life: A buyer's guide

Everything you could ever want to know about biotech, biomed and bio investments up north.

Tony Pullen   January 21, 2014
0 stars

Insider Deals: Gold Canyon (V.GCU), Metro (T.MRU) and Yellow Media (T.Y) insiders buy up

Chris Parry   November 27, 2013
0 stars

Mystery Movers: Biomed shares surging, triple digit rises all over, executives baffled

When you're standing on a launchpad and a rocket is taking off, the best place to be is on the rocket.

Chris Parry   November 19, 2013
0 stars

Latest Bullboard Posts

  • RE:RE:E Wts.

    0 stars

    I added more C's on Friday (intrinsic value is currently $0.52 with 3 years to run) I know bayou, I'm like a broken record. GLTA

    3 stars

  • RE:E Wts.

    0 stars

    Easy come. Easy go. Down 51% today.

    2 stars

  • E Wts.

    0 stars

    Love those E Wts!  +96%.  Hope you other guys are making a bunch too!

    3.5 stars

  • Titan Medical Inc. Completes the Next Major Milestone

    0 stars

    TORONTO, ON--(Marketwired - March 17, 2015) - Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD)(OTCQX: TITXF)today announced that...

    2 stars

  • RE:Feasibility prototype

    0 stars

    Finally the stock closed up for the day. Hope as well that the feasibility prototype is on target. A small delay would not upset me, but...

    2 stars